14-day Premium Trial Subscription Try For FreeTry Free
$141.71
+1.00 (+0.711%)
At Close: May 06, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 15, 2024 Buy 12 587 Benevich Eric Common Stock
Apr 15, 2024 Buy 7 231 Benevich Eric Common Stock
Apr 15, 2024 Sell 12 587 Benevich Eric Common Stock
Apr 15, 2024 Sell 7 231 Benevich Eric Non-Qualified Stock Option
Apr 15, 2024 Sell 12 587 Benevich Eric Non-Qualified Stock Option
Apr 01, 2024 Buy 272 Delaet Ingrid Common Stock
Apr 01, 2024 Sell 272 Delaet Ingrid Common Stock
Apr 01, 2024 Sell 272 Delaet Ingrid Non-Qualified Stock Option
Mar 21, 2024 Sell 5 000 Delaet Ingrid Non-Qualified Stock Option
Mar 21, 2024 Buy 5 000 Delaet Ingrid Common Stock
Mar 21, 2024 Sell 5 000 Delaet Ingrid Common Stock
Mar 14, 2024 Buy 69 521 Benevich Eric Common Stock
Mar 14, 2024 Buy 5 479 Benevich Eric Common Stock
Mar 14, 2024 Sell 69 521 Benevich Eric Common Stock
Mar 14, 2024 Sell 5 479 Benevich Eric Non-Qualified Stock Option
Mar 14, 2024 Sell 69 521 Benevich Eric Non-Qualified Stock Option
Mar 14, 2024 Buy 20 000 Morrow George J Common Stock
Mar 14, 2024 Sell 20 000 Morrow George J Non-Qualified Stock Option
Mar 14, 2024 Sell 20 000 Morrow George J Common Stock
Mar 14, 2024 Sell 20 000 Morrow George J Non-Qualified Stock Option
Mar 14, 2024 Sell 20 000 Morrow George J Common Stock
Mar 13, 2024 Buy 23 200 Pops Richard F Common Stock
Mar 13, 2024 Sell 23 200 Pops Richard F Common Stock
Mar 13, 2024 Sell 23 200 Pops Richard F Non-Qualified Stock Option
Mar 13, 2024 Buy 3 000 Delaet Ingrid Common Stock
Mar 13, 2024 Sell 3 000 Delaet Ingrid Common Stock
Mar 13, 2024 Sell 3 000 Delaet Ingrid Non-Qualified Stock Option
Mar 11, 2024 Buy 100 Pops Richard F Common Stock
Mar 11, 2024 Sell 100 Pops Richard F Common Stock
Mar 11, 2024 Sell 100 Pops Richard F Non-Qualified Stock Option
Mar 11, 2024 Buy 200 Delaet Ingrid Common Stock
Mar 11, 2024 Sell 200 Delaet Ingrid Common Stock
Mar 11, 2024 Sell 200 Delaet Ingrid Non-Qualified Stock Option
Mar 08, 2024 Buy 1 700 Pops Richard F Common Stock
Mar 08, 2024 Sell 1 700 Pops Richard F Common Stock
Mar 08, 2024 Sell 1 700 Pops Richard F Non-Qualified Stock Option
Mar 08, 2024 Buy 1 800 Delaet Ingrid Common Stock
Mar 08, 2024 Sell 1 800 Delaet Ingrid Non-Qualified Stock Option
Mar 08, 2024 Sell 1 800 Delaet Ingrid Common Stock
Feb 29, 2024 Buy 273 Delaet Ingrid Common Stock
Feb 29, 2024 Sell 273 Delaet Ingrid Common Stock
Feb 29, 2024 Sell 273 Delaet Ingrid Non-Qualified Stock Option
Feb 28, 2024 Buy 2 500 Delaet Ingrid Common Stock
Feb 28, 2024 Sell 2 500 Delaet Ingrid Non-Qualified Stock Option
Feb 28, 2024 Buy 1 544 Delaet Ingrid Common Stock
Feb 28, 2024 Sell 2 500 Delaet Ingrid Common Stock
Feb 28, 2024 Sell 2 500 Delaet Ingrid Common Stock
Feb 28, 2024 Sell 1 544 Delaet Ingrid Common Stock
Feb 28, 2024 Sell 2 500 Delaet Ingrid Non-Qualified Stock Option
Feb 28, 2024 Sell 1 544 Delaet Ingrid Non-Qualified Stock Option
Feb 28, 2024 Buy 53 143 Benevich Eric Common Stock
Feb 28, 2024 Buy 21 857 Benevich Eric Common Stock
Feb 28, 2024 Sell 21 857 Benevich Eric Common Stock
Feb 28, 2024 Sell 21 857 Benevich Eric Non-Qualified Stock Option
Feb 28, 2024 Sell 53 143 Benevich Eric Non-Qualified Stock Option
Feb 27, 2024 Buy 8 000 Norwalk Leslie V Common Stock
Feb 27, 2024 Sell 8 000 Norwalk Leslie V Non-Qualified Stock Option
Feb 27, 2024 Sell 8 000 Norwalk Leslie V Common Stock
Feb 20, 2024 Buy 15 000 Pops Richard F Common Stock
Feb 20, 2024 Sell 15 000 Pops Richard F Common Stock
Feb 20, 2024 Sell 15 000 Pops Richard F Non-Qualified Stock Option
Feb 13, 2024 Sell 1 114 Roberts Eiry Common Stock
Feb 13, 2024 Buy 22 529 Roberts Eiry Stock Option
Feb 13, 2024 Buy 4 483 Roberts Eiry Restricted Stock Unit
Feb 13, 2024 Buy 54 069 Onyia Jude Stock Option
Feb 13, 2024 Sell 1 432 Onyia Jude Common Stock
Feb 13, 2024 Buy 10 760 Onyia Jude Restricted Stock Unit
Feb 13, 2024 Buy 40 552 Lippoldt Darin Stock Option
Feb 13, 2024 Sell 1 098 Lippoldt Darin Common Stock
Feb 13, 2024 Buy 8 070 Lippoldt Darin Restricted Stock Unit
Feb 13, 2024 Sell 2 832 Gorman Kevin Charles Common Stock
Feb 13, 2024 Buy 112 644 Gorman Kevin Charles Stock Option
Feb 13, 2024 Buy 22 415 Gorman Kevin Charles Restricted Stock Unit
Feb 13, 2024 Sell 1 352 Gano Kyle Common Stock
Feb 13, 2024 Buy 45 058 Gano Kyle Stock Option
Feb 13, 2024 Buy 8 966 Gano Kyle Restricted Stock Unit
Feb 13, 2024 Buy 28 161 Delaet Ingrid Stock Option
Feb 13, 2024 Sell 716 Delaet Ingrid Common Stock
Feb 13, 2024 Buy 5 604 Delaet Ingrid Restricted Stock Unit
Feb 13, 2024 Buy 28 161 Cooke Julie Stock Option
Feb 13, 2024 Sell 796 Cooke Julie Common Stock
Feb 13, 2024 Buy 5 604 Cooke Julie Restricted Stock Unit
Feb 13, 2024 Buy 30 977 Boyer David W. Stock Option
Feb 13, 2024 Buy 6 165 Boyer David W. Restricted Stock Unit
Feb 13, 2024 Sell 955 Boyer David W. Common Stock
Feb 13, 2024 Sell 856 Boyer David W. Common Stock
Feb 13, 2024 Sell 1 098 Benevich Eric Common Stock
Feb 13, 2024 Buy 39 426 Benevich Eric Stock Option
Feb 13, 2024 Buy 7 846 Benevich Eric Restricted Stock Unit
Feb 13, 2024 Buy 45 058 Abernethy Matt Stock Option
Feb 13, 2024 Sell 1 352 Abernethy Matt Common Stock
Feb 13, 2024 Buy 8 966 Abernethy Matt Restricted Stock Unit
Feb 13, 2024 Buy 2 312 Gorman Kevin Charles Common Stock
Feb 13, 2024 Buy 2 778 Gorman Kevin Charles Common Stock
Feb 13, 2024 Sell 2 778 Gorman Kevin Charles Incentive Stock Option
Feb 13, 2024 Sell 2 312 Gorman Kevin Charles Incentive Stock Option
Feb 08, 2024 Sell 700 Boyer David W. Common Stock
Feb 08, 2024 Sell 628 Boyer David W. Common Stock
Feb 06, 2024 Sell 240 Boyer David W. Common Stock
Feb 06, 2024 Sell 216 Boyer David W. Common Stock
JSON CSV
INSIDER POWER
20.392
Last 100 transactions
Buy: 793 011 | Sell: 504 436 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 20.392.

In total, the insiders bought 793 011 and sold 504 436 NBIX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Neurocrine Biosciences

Neurocrine Biosciences Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON... NBIX Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT